Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2248 participants
OBSERVATIONAL
2010-06-30
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment Choice and Outcomes for ESRD: Evidence From the First Year of a Nationwide Randomized Evaluation
NCT05005572
A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis
NCT00214721
Seasonal Differences in Home Dialysis Uptake and Initiating Dialysis in the Hospital
NCT04935827
Using Intradialytic Blood Pressure Slopes to Guide Ultrafiltration
NCT03303391
Evaluation of a Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease
NCT06219798
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
Patients with end-stage renal disease (ESRD) treated at small dialysis organizations (SDOs).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Documented physician diagnosis of ESRD requiring dialysis and receiving care at a participating dialysis center
* Undergoing dialysis on the dialysis schedule assigned to the site
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amgen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MD
Role: STUDY_DIRECTOR
Amgen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Gulf Shores, Alabama, United States
Research Site
Siloam Springs, Arkansas, United States
Research Site
Springdale, Arkansas, United States
Research Site
Azusa, California, United States
Research Site
Bakersfield, California, United States
Research Site
Covina, California, United States
Research Site
Glendale, California, United States
Research Site
Hacienda Heights, California, United States
Research Site
Inglewood, California, United States
Research Site
Lancaster, California, United States
Research Site
Los Angeles, California, United States
Research Site
Northridge, California, United States
Research Site
San Dimas, California, United States
Research Site
West Covina, California, United States
Research Site
Whittier, California, United States
Research Site
Pembroke Pines, Florida, United States
Research Site
Blairsville, Georgia, United States
Research Site
East Point, Georgia, United States
Research Site
Honolulu, Hawaii, United States
Research Site
Honolulu, Hawaii, United States
Research Site
Quincy, Illinois, United States
Research Site
Columbia, Mississippi, United States
Research Site
Pachuta, Mississippi, United States
Research Site
Lincoln, Nebraska, United States
Research Site
Lincoln, Nebraska, United States
Research Site
Lincoln, Nebraska, United States
Research Site
Livingston, New Jersey, United States
Research Site
Brooklyn, New York, United States
Research Site
Maspeth, New York, United States
Research Site
New York, New York, United States
Research Site
The Bronx, New York, United States
Research Site
King, North Carolina, United States
Research Site
Winston-Salem, North Carolina, United States
Research Site
Yadkinville, North Carolina, United States
Research Site
Arlington, Texas, United States
Research Site
Houston, Texas, United States
Research Site
Houston, Texas, United States
Research Site
Houston, Texas, United States
Research Site
Fairfax, Virginia, United States
Research Site
South Charleston, West Virginia, United States
Research Site
San Juan, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
AmgenTrials clinical trials website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20080234
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.